Benzinga Rankings give you vital metrics on any stock – anytime.
Explore CERo Therapeutics Hldgs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CERO.
You can purchase shares of CERo Therapeutics Hldgs (NASDAQ:CERO) through any online brokerage.
Other companies in CERo Therapeutics Hldgs’s space includes: Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX) and Palisade Bio (NASDAQ:PALI).
CERo Therapeutics Hldgs has a consensus price target of $11.00.
The stock price for CERo Therapeutics Hldgs (NASDAQ: CERO) is $0.5702 last updated May 15, 2025 at 6:23 PM EDT.
There are no upcoming dividends for CERo Therapeutics Hldgs.
CERo Therapeutics Hldgs’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
There is no upcoming split for CERo Therapeutics Hldgs.
CERo Therapeutics Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.